Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) EBIT : €3.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Fine Foods & Pharmaceuticals NTM SpA EBIT?

Fine Foods & Pharmaceuticals NTM SpA's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was €-1.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was €3.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Fine Foods & Pharmaceuticals NTM SpA's annualized ROC % for the quarter that ended in Dec. 2023 was 9.57%. Fine Foods & Pharmaceuticals NTM SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -2.65%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Fine Foods & Pharmaceuticals NTM SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1.17%.

Fine Foods & Pharmaceuticals NTM SpA EBIT Historical Data

The historical data trend for Fine Foods & Pharmaceuticals NTM SpA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fine Foods & Pharmaceuticals NTM SpA EBIT Chart

Fine Foods & Pharmaceuticals NTM SpA Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

0.61

17.17

-3.89

-12.17

2.95

Fine Foods & Pharmaceuticals NTM SpA Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial															-2.03	5.32	-3.18	1.86	-1.05

Competitive Comparison of Fine Foods & Pharmaceuticals NTM SpA's EBIT

For the Packaged Foods subindustry, Fine Foods & Pharmaceuticals NTM SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fine Foods & Pharmaceuticals NTM SpA's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Fine Foods & Pharmaceuticals NTM SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fine Foods & Pharmaceuticals NTM SpA's EV-to-EBIT falls into.

Fine Foods & Pharmaceuticals NTM SpA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.0 Mil.

Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Fine Foods & Pharmaceuticals NTM SpA's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	25.372 * ( 1 - 25.56% )	/	( (196.044	+	198.583)	/ 2 )
=	18.8869168	/	197.3135
=	9.57 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	272.654	-	31.503	-	( 45.107	-	max(0, 76.997	-	142.477	+	45.107	))
=	196.044

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	241.562	-	32.945	-	( 22.833	-	max(0, 101.378	-	111.412	+	22.833	))
=	198.583

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Fine Foods & Pharmaceuticals NTM SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-4.196	/	( ( (109.405 + max(54.741, 0))	+	(110.085 + max(42.198, 0)) )	/	2 )
=	-4.196	/	( ( 164.146	+	152.283 )	/	2 )
=	-4.196	/	158.2145
=	-2.65 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(41.916	+	47.281	+	8.173)	-	(31.503	+	0	+	11.126)
=	54.741

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(38.058	+	42.46	+	7.434)	-	(32.945	+	0	+	12.809)
=	42.198

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Fine Foods & Pharmaceuticals NTM SpA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	2.952	/	252.149
	=	1.17 %

Fine Foods & Pharmaceuticals NTM SpA EBIT Related Terms

Thank you for viewing the detailed overview of Fine Foods & Pharmaceuticals NTM SpA's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

9S5:Germany

Address

Via Berlino, 39, Verdellino, Zingonia, Bergamo, ITA, 24040

Website

https://www.finefoods.it

Fine Foods & Pharmaceuticals NTM SpA is engaged in contract development and manufacturing of pharmaceuticals, nutraceuticals, and medical devices in solid oral forms. The company produces pharmaceutical products such as powders and granules, tablets, film tablets, and hard gelatin capsules, packed in sachets, blisters, and pillows.